20.09.2013 • NewsBayerDiabetes Carediabetes treatment

Roche Decides Against Selling Diabetes Device Unit

Swiss drugmaker Roche has decided against trying to sell its blood glucose meter business, according to two people familiar with the matter.

In the past few months, Roche was looking to sell the business as the industry faced increased competition and lower reimbursement rates from U.S. government healthcare programs,

However, the reimbursement pressure on diabetes test supplies lessened the chances of a competitive sales process, leaving Roche little choice but to hold on to the business, according to one of the people who spoke to Reuters this week.

A Roche spokesperson said in an email that the company remains committed to its Diabetes Care division.

Bayer, Germany's biggest drugmaker, had attempted to sell its blood glucose meter business for about $1.5 billion, only to pull the plug on the sale early this year after failing to attract sufficient interest.

The diabetes device market came under pressure earlier this year after the U.S. Centers for Medicare & Medicaid Services moved to cut the reimbursement for diabetes test supplies by up to 72 %. The change, which took effect in July, makes it more difficult for companies to be profitable in this business.

 

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.

Photo
27.03.2025 • News

Moeve Joins Global Impact Coalition

The Global Impact Coalition (GIC), a collaborative platform led by CEOs and focused on achieving a net-zero chemicals future, has announced the addition of Moeve as its newest member.